|1.18||-0.02 / -1.67%|
As of Mar 31
|1.17||-0.01 / -0.85%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +408.47% increase from the last price of 1.18.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.